Anton Gueth, Director at ANTARES PHARMA, INC. (ATRS), sold 25,000 shares at $4.01 ($100K) on 2013-06-03, disclosed to the SEC on 2013-06-05.
Scheduled sale ($100k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRS | BUY | 2014-08-13 | $10K | — | Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |